Nursing homes are now required to test staff and offer COVID-19 tests to residents, according to new guidelines from the Centers for Medicare and Medicaid Services. The agency also released $5 billion to help nursing homes address critical needs, including hiring additional staff and increasing testing. (Reuters)

The Justice Department plans to charge Teva in a price-fixing investigation. The government was investigating whether Teva conspired with competitors to raise prices on generic drugs. The company reportedly refused to settle the lawsuit and admit wrongdoing. (Bloomberg)

Verily is creating a subsidiary dedicated to stop-loss insurance. Verily, owned by Alphabet, received an investment from Swiss Re to start the subsidiary. It plans to bring tech and data science to the stop-loss health insurance field. (CNBC)

AstraZeneca began phase 1 trials of its COVID-19 antibody treatment. The combination drug is being tested in a small group, with results expected later this year. AstraZeneca is the third company to begin human trials of a coronavirus antibody drug, following Regeneron and Eli Lilly. (BioPharma Dive)

Translate Bio and Sanofi’s coronavirus vaccine produced an immune response in animal studies. The two companies expect human trials to begin in November. Sanofi signed a $2 billion deal to develop the vaccine with Translate Bio last month. (Reuters)